#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=Naturally , as the VAD and the controller are implanted in humans , because their lifespan depends largely on the suitability of the pump control , we must have great certainty in the robustness of the control algorithms .
2-1	14-23	Naturally	_	_	_	_
2-2	24-25	,	_	_	_	_
2-3	26-28	as	_	_	_	_
2-4	29-32	the	abstract[2]	new[2]	_	_
2-5	33-36	VAD	abstract[2]	new[2]	_	_
2-6	37-40	and	_	_	_	_
2-7	41-44	the	object[3]	new[3]	coref	9-11[66_3]
2-8	45-55	controller	object[3]	new[3]	_	_
2-9	56-59	are	_	_	_	_
2-10	60-69	implanted	_	_	_	_
2-11	70-72	in	_	_	_	_
2-12	73-79	humans	animal	new	ana	2-15
2-13	80-81	,	_	_	_	_
2-14	82-89	because	_	_	_	_
2-15	90-95	their	animal|abstract[6]	giv|new[6]	_	_
2-16	96-104	lifespan	abstract[6]	new[6]	_	_
2-17	105-112	depends	_	_	_	_
2-18	113-120	largely	_	_	_	_
2-19	121-123	on	_	_	_	_
2-20	124-127	the	abstract[7]	new[7]	_	_
2-21	128-139	suitability	abstract[7]	new[7]	_	_
2-22	140-142	of	abstract[7]	new[7]	_	_
2-23	143-146	the	abstract[7]|event[9]	new[7]|new[9]	coref	2-37[0_9]
2-24	147-151	pump	abstract[7]|object|event[9]	new[7]|new|new[9]	coref	8-1[55_0]
2-25	152-159	control	abstract[7]|event[9]	new[7]|new[9]	_	_
2-26	160-161	,	_	_	_	_
2-27	162-164	we	person	acc	ana	7-1
2-28	165-169	must	_	_	_	_
2-29	170-174	have	_	_	_	_
2-30	175-180	great	abstract[11]	new[11]	_	_
2-31	181-190	certainty	abstract[11]	new[11]	_	_
2-32	191-193	in	abstract[11]	new[11]	_	_
2-33	194-197	the	abstract[11]|abstract[12]	new[11]|new[12]	_	_
2-34	198-208	robustness	abstract[11]|abstract[12]	new[11]|new[12]	_	_
2-35	209-211	of	abstract[11]|abstract[12]	new[11]|new[12]	_	_
2-36	212-215	the	abstract[11]|abstract[12]|abstract[14]	new[11]|new[12]|new[14]	_	_
2-37	216-223	control	abstract[11]|abstract[12]|event|abstract[14]	new[11]|new[12]|giv|new[14]	coref	4-7[28_0]
2-38	224-234	algorithms	abstract[11]|abstract[12]|abstract[14]	new[11]|new[12]|new[14]	_	_
2-39	235-236	.	_	_	_	_

#Text=Continuous flow for VADs may allow simulated pulses ; however , until the date of circulatory assistance , despite tolerance to left ventricular and Pao , the continuous flow rate is traditionally of a medium constant rotation , which always decreases the pressure pulse .
3-1	237-247	Continuous	abstract[15]	new[15]	coref	3-29[0_15]
3-2	248-252	flow	abstract[15]	new[15]	_	_
3-3	253-256	for	abstract[15]	new[15]	_	_
3-4	257-261	VADs	abstract[15]|abstract	new[15]|new	_	_
3-5	262-265	may	_	_	_	_
3-6	266-271	allow	_	_	_	_
3-7	272-281	simulated	abstract[17]	new[17]	_	_
3-8	282-288	pulses	abstract[17]	new[17]	_	_
3-9	289-290	;	_	_	_	_
3-10	291-298	however	_	_	_	_
3-11	299-300	,	_	_	_	_
3-12	301-306	until	_	_	_	_
3-13	307-310	the	time[18]	new[18]	_	_
3-14	311-315	date	time[18]	new[18]	_	_
3-15	316-318	of	time[18]	new[18]	_	_
3-16	319-330	circulatory	time[18]|event[19]	new[18]|new[19]	_	_
3-17	331-341	assistance	time[18]|event[19]	new[18]|new[19]	_	_
3-18	342-343	,	_	_	_	_
3-19	344-351	despite	_	_	_	_
3-20	352-361	tolerance	abstract[20]	new[20]	_	_
3-21	362-364	to	abstract[20]	new[20]	_	_
3-22	365-369	left	abstract[20]	new[20]	_	_
3-23	370-381	ventricular	abstract[20]	new[20]	_	_
3-24	382-385	and	abstract[20]	new[20]	_	_
3-25	386-389	Pao	abstract[20]|object	new[20]|new	_	_
3-26	390-391	,	_	_	_	_
3-27	392-395	the	abstract[23]	new[23]	coref	10-13[81_23]
3-28	396-406	continuous	abstract[23]	new[23]	_	_
3-29	407-411	flow	abstract|abstract[23]	giv|new[23]	coref	4-16
3-30	412-416	rate	abstract[23]	new[23]	_	_
3-31	417-419	is	_	_	_	_
3-32	420-433	traditionally	event[24]	new[24]	_	_
3-33	434-436	of	event[24]	new[24]	_	_
3-34	437-438	a	event[24]	new[24]	_	_
3-35	439-445	medium	event[24]	new[24]	_	_
3-36	446-454	constant	event[24]	new[24]	_	_
3-37	455-463	rotation	event[24]	new[24]	_	_
3-38	464-465	,	event[24]	new[24]	_	_
3-39	466-471	which	event[24]	new[24]	_	_
3-40	472-478	always	event[24]	new[24]	_	_
3-41	479-488	decreases	event[24]	new[24]	_	_
3-42	489-492	the	event[24]|abstract[26]	new[24]|new[26]	_	_
3-43	493-501	pressure	event[24]|abstract|abstract[26]	new[24]|new|new[26]	coref	4-18
3-44	502-507	pulse	event[24]|abstract[26]	new[24]|new[26]	_	_
3-45	508-509	.	_	_	_	_

#Text=These types of devices generally require precise control and the use of sensors to measure flow and pressure .
4-1	510-515	These	object[27]	new[27]	coref	5-1[33_27]
4-2	516-521	types	object[27]	new[27]	_	_
4-3	522-524	of	object[27]	new[27]	_	_
4-4	525-532	devices	object[27]	new[27]	_	_
4-5	533-542	generally	_	_	_	_
4-6	543-550	require	_	_	_	_
4-7	551-558	precise	event[28]	giv[28]	coref	10-3[0_28]
4-8	559-566	control	event[28]	giv[28]	_	_
4-9	567-570	and	_	_	_	_
4-10	571-574	the	event[29]	new[29]	_	_
4-11	575-578	use	event[29]	new[29]	_	_
4-12	579-581	of	event[29]	new[29]	_	_
4-13	582-589	sensors	event[29]|object[30]	new[29]|new[30]	coref	6-7[40_30]
4-14	590-592	to	event[29]|object[30]	new[29]|new[30]	_	_
4-15	593-600	measure	event[29]|object[30]	new[29]|new[30]	_	_
4-16	601-605	flow	event[29]|object[30]|abstract	new[29]|new[30]|giv	coref	8-3
4-17	606-609	and	event[29]|object[30]	new[29]|new[30]	_	_
4-18	610-618	pressure	event[29]|object[30]|abstract	new[29]|new[30]|giv	coref	8-12[59_0]
4-19	619-620	.	_	_	_	_

#Text=These devices are not reliable , owing to clinical issues such as routine calibration and blood clotting .
5-1	621-626	These	object[33]	giv[33]	_	_
5-2	627-634	devices	object[33]	giv[33]	_	_
5-3	635-638	are	_	_	_	_
5-4	639-642	not	_	_	_	_
5-5	643-651	reliable	_	_	_	_
5-6	652-653	,	_	_	_	_
5-7	654-659	owing	_	_	_	_
5-8	660-662	to	_	_	_	_
5-9	663-671	clinical	abstract[34]	new[34]	_	_
5-10	672-678	issues	abstract[34]	new[34]	_	_
5-11	679-683	such	abstract[34]	new[34]	_	_
5-12	684-686	as	abstract[34]	new[34]	_	_
5-13	687-694	routine	abstract[34]|abstract[35]	new[34]|new[35]	_	_
5-14	695-706	calibration	abstract[34]|abstract[35]	new[34]|new[35]	_	_
5-15	707-710	and	abstract[34]	new[34]	_	_
5-16	711-716	blood	abstract[34]|substance|event[37]	new[34]|new|new[37]	_	_
5-17	717-725	clotting	abstract[34]|event[37]	new[34]|new[37]	_	_
5-18	726-727	.	_	_	_	_

#Text=These concerns regarding the reliability of implantable sensors have led to the search for non-invasive , sensorless approaches to identifying analog cardiac preload .
6-1	728-733	These	abstract[38]	new[38]	_	_
6-2	734-742	concerns	abstract[38]	new[38]	_	_
6-3	743-752	regarding	abstract[38]	new[38]	_	_
6-4	753-756	the	abstract[38]|abstract[39]	new[38]|new[39]	_	_
6-5	757-768	reliability	abstract[38]|abstract[39]	new[38]|new[39]	_	_
6-6	769-771	of	abstract[38]|abstract[39]	new[38]|new[39]	_	_
6-7	772-783	implantable	abstract[38]|abstract[39]|object[40]	new[38]|new[39]|giv[40]	_	_
6-8	784-791	sensors	abstract[38]|abstract[39]|object[40]	new[38]|new[39]|giv[40]	_	_
6-9	792-796	have	_	_	_	_
6-10	797-800	led	_	_	_	_
6-11	801-803	to	_	_	_	_
6-12	804-807	the	event[41]	new[41]	_	_
6-13	808-814	search	event[41]	new[41]	_	_
6-14	815-818	for	event[41]	new[41]	_	_
6-15	819-831	non-invasive	event[41]|abstract[42]	new[41]|new[42]	coref	13-19[115_42]
6-16	832-833	,	event[41]|abstract[42]	new[41]|new[42]	_	_
6-17	834-844	sensorless	event[41]|abstract[42]	new[41]|new[42]	_	_
6-18	845-855	approaches	event[41]|abstract[42]	new[41]|new[42]	_	_
6-19	856-858	to	event[41]|abstract[42]	new[41]|new[42]	_	_
6-20	859-870	identifying	event[41]|abstract[42]	new[41]|new[42]	_	_
6-21	871-877	analog	event[41]|abstract[42]|abstract[43]	new[41]|new[42]|new[43]	coref	12-11[0_43]
6-22	878-885	cardiac	event[41]|abstract[42]|abstract[43]	new[41]|new[42]|new[43]	_	_
6-23	886-893	preload	event[41]|abstract[42]|abstract[43]	new[41]|new[42]|new[43]	_	_
6-24	894-895	.	_	_	_	_

#Text=We now believe that non-invasive technology has advanced to a level where it can be considered for long-term implantation , combined with sensorless signals , to form a robust control system that provides physiological behavior to RBPs .
7-1	896-898	We	person	giv	ana	9-26
7-2	899-902	now	_	_	_	_
7-3	903-910	believe	_	_	_	_
7-4	911-915	that	_	_	_	_
7-5	916-928	non-invasive	abstract[45]	new[45]	_	_
7-6	929-939	technology	abstract[45]	new[45]	_	_
7-7	940-943	has	_	_	_	_
7-8	944-952	advanced	_	_	_	_
7-9	953-955	to	_	_	_	_
7-10	956-957	a	abstract[46]	new[46]	ana	7-13[0_46]
7-11	958-963	level	abstract[46]	new[46]	_	_
7-12	964-969	where	abstract[46]	new[46]	_	_
7-13	970-972	it	abstract[46]|abstract	new[46]|giv	_	_
7-14	973-976	can	abstract[46]	new[46]	_	_
7-15	977-979	be	abstract[46]	new[46]	_	_
7-16	980-990	considered	abstract[46]	new[46]	_	_
7-17	991-994	for	abstract[46]	new[46]	_	_
7-18	995-1004	long-term	abstract[46]|event[48]	new[46]|new[48]	_	_
7-19	1005-1017	implantation	abstract[46]|event[48]	new[46]|new[48]	_	_
7-20	1018-1019	,	abstract[46]	new[46]	_	_
7-21	1020-1028	combined	abstract[46]	new[46]	_	_
7-22	1029-1033	with	abstract[46]	new[46]	_	_
7-23	1034-1044	sensorless	abstract[46]|abstract[49]	new[46]|new[49]	_	_
7-24	1045-1052	signals	abstract[46]|abstract[49]	new[46]|new[49]	_	_
7-25	1053-1054	,	abstract[46]	new[46]	_	_
7-26	1055-1057	to	abstract[46]	new[46]	_	_
7-27	1058-1062	form	abstract[46]	new[46]	_	_
7-28	1063-1064	a	abstract[46]|abstract[51]	new[46]|new[51]	_	_
7-29	1065-1071	robust	abstract[46]|abstract[51]	new[46]|new[51]	_	_
7-30	1072-1079	control	abstract[46]|person|abstract[51]	new[46]|new|new[51]	_	_
7-31	1080-1086	system	abstract[46]|abstract[51]	new[46]|new[51]	_	_
7-32	1087-1091	that	abstract[46]|abstract[51]	new[46]|new[51]	_	_
7-33	1092-1100	provides	abstract[46]|abstract[51]	new[46]|new[51]	_	_
7-34	1101-1114	physiological	abstract[46]|abstract[51]|abstract[52]	new[46]|new[51]|new[52]	_	_
7-35	1115-1123	behavior	abstract[46]|abstract[51]|abstract[52]	new[46]|new[51]|new[52]	_	_
7-36	1124-1126	to	abstract[46]|abstract[51]	new[46]|new[51]	_	_
7-37	1127-1131	RBPs	abstract[46]|abstract[51]|abstract	new[46]|new[51]|new	_	_
7-38	1132-1133	.	_	_	_	_

#Text=The pulsatile flow pump is used as a non-invasive substitute for the LV filling pressure , as it has been proven to be closely interrelated .
8-1	1134-1137	The	object[55]	giv[55]	coref	9-2[0_55]
8-2	1138-1147	pulsatile	object[55]	giv[55]	_	_
8-3	1148-1152	flow	abstract|object[55]	giv|giv[55]	coref	9-2[62_0]
8-4	1153-1157	pump	object[55]	giv[55]	_	_
8-5	1158-1160	is	_	_	_	_
8-6	1161-1165	used	_	_	_	_
8-7	1166-1168	as	_	_	_	_
8-8	1169-1170	a	substance[56]	new[56]	_	_
8-9	1171-1183	non-invasive	substance[56]	new[56]	_	_
8-10	1184-1194	substitute	substance[56]	new[56]	_	_
8-11	1195-1198	for	substance[56]	new[56]	_	_
8-12	1199-1202	the	substance[56]|abstract[59]	new[56]|giv[59]	ana	8-18[0_59]
8-13	1203-1205	LV	substance[56]|substance|abstract[59]	new[56]|new|giv[59]	_	_
8-14	1206-1213	filling	substance[56]|abstract|abstract[59]	new[56]|new|giv[59]	_	_
8-15	1214-1222	pressure	substance[56]|abstract[59]	new[56]|giv[59]	_	_
8-16	1223-1224	,	_	_	_	_
8-17	1225-1227	as	_	_	_	_
8-18	1228-1230	it	abstract	giv	_	_
8-19	1231-1234	has	_	_	_	_
8-20	1235-1239	been	_	_	_	_
8-21	1240-1246	proven	_	_	_	_
8-22	1247-1249	to	_	_	_	_
8-23	1250-1252	be	_	_	_	_
8-24	1253-1260	closely	_	_	_	_
8-25	1261-1273	interrelated	_	_	_	_
8-26	1274-1275	.	_	_	_	_

#Text=The pump flow pulsation and mean flow pump used in the current controller can be estimated using an algorithm for flow estimation previously established in our laboratory using the pump speed and current that are not measured invasively .
9-1	1276-1279	The	abstract[63]	new[63]	_	_
9-2	1280-1284	pump	object|abstract[62]|abstract[63]	giv|giv[62]|new[63]	coref|coref	9-6[64_62]|9-6[65_0]
9-3	1285-1289	flow	abstract[62]|abstract[63]	giv[62]|new[63]	_	_
9-4	1290-1299	pulsation	abstract[63]	new[63]	_	_
9-5	1300-1303	and	_	_	_	_
9-6	1304-1308	mean	abstract[64]|object[65]	giv[64]|giv[65]	coref|coref	9-21[0_64]|9-30[0_65]
9-7	1309-1313	flow	abstract[64]|object[65]	giv[64]|giv[65]	_	_
9-8	1314-1318	pump	object[65]	giv[65]	_	_
9-9	1319-1323	used	object[65]	giv[65]	_	_
9-10	1324-1326	in	object[65]	giv[65]	_	_
9-11	1327-1330	the	object[65]|object[66]	giv[65]|giv[66]	_	_
9-12	1331-1338	current	object[65]|object[66]	giv[65]|giv[66]	_	_
9-13	1339-1349	controller	object[65]|object[66]	giv[65]|giv[66]	_	_
9-14	1350-1353	can	_	_	_	_
9-15	1354-1356	be	_	_	_	_
9-16	1357-1366	estimated	_	_	_	_
9-17	1367-1372	using	_	_	_	_
9-18	1373-1375	an	abstract[67]	new[67]	_	_
9-19	1376-1385	algorithm	abstract[67]	new[67]	_	_
9-20	1386-1389	for	abstract[67]	new[67]	_	_
9-21	1390-1394	flow	abstract[67]|abstract|abstract[69]	new[67]|giv|new[69]	coref	10-6
9-22	1395-1405	estimation	abstract[67]|abstract[69]	new[67]|new[69]	_	_
9-23	1406-1416	previously	abstract[67]|abstract[69]	new[67]|new[69]	_	_
9-24	1417-1428	established	abstract[67]|abstract[69]	new[67]|new[69]	_	_
9-25	1429-1431	in	abstract[67]|abstract[69]	new[67]|new[69]	_	_
9-26	1432-1435	our	abstract[67]|abstract[69]|person|place[71]	new[67]|new[69]|giv|new[71]	ana	11-1[0_71]
9-27	1436-1446	laboratory	abstract[67]|abstract[69]|place[71]	new[67]|new[69]|new[71]	_	_
9-28	1447-1452	using	_	_	_	_
9-29	1453-1456	the	abstract[73]	new[73]	coref	14-23[125_73]
9-30	1457-1461	pump	object|abstract[73]	giv|new[73]	coref	11-19
9-31	1462-1467	speed	abstract[73]	new[73]	_	_
9-32	1468-1471	and	_	_	_	_
9-33	1472-1479	current	abstract[74]	new[74]	_	_
9-34	1480-1484	that	abstract[74]	new[74]	_	_
9-35	1485-1488	are	abstract[74]	new[74]	_	_
9-36	1489-1492	not	abstract[74]	new[74]	_	_
9-37	1493-1501	measured	abstract[74]	new[74]	_	_
9-38	1502-1512	invasively	abstract[74]	new[74]	_	_
9-39	1513-1514	.	_	_	_	_

#Text=The current control approach uses flow pulsatility as a parameter to determine the required flow rate compared to the continuous pulsatility index ( PI ) control strategy , which regulates PI directly at a specific stage .
10-1	1515-1518	The	abstract[76]	new[76]	_	_
10-2	1519-1526	current	abstract[76]	new[76]	_	_
10-3	1527-1534	control	event|abstract[76]	giv|new[76]	coref	10-26
10-4	1535-1543	approach	abstract[76]	new[76]	_	_
10-5	1544-1548	uses	_	_	_	_
10-6	1549-1553	flow	abstract|abstract[78]	giv|new[78]	coref|coref	10-15|10-21[0_78]
10-7	1554-1565	pulsatility	abstract[78]	new[78]	_	_
10-8	1566-1568	as	_	_	_	_
10-9	1569-1570	a	abstract[79]	new[79]	_	_
10-10	1571-1580	parameter	abstract[79]	new[79]	_	_
10-11	1581-1583	to	_	_	_	_
10-12	1584-1593	determine	_	_	_	_
10-13	1594-1597	the	abstract[81]	giv[81]	_	_
10-14	1598-1606	required	abstract[81]	giv[81]	_	_
10-15	1607-1611	flow	abstract|abstract[81]	giv|giv[81]	_	_
10-16	1612-1616	rate	abstract[81]	giv[81]	_	_
10-17	1617-1625	compared	_	_	_	_
10-18	1626-1628	to	_	_	_	_
10-19	1629-1632	the	abstract[86]	new[86]	_	_
10-20	1633-1643	continuous	abstract[83]|abstract[86]	new[83]|new[86]	appos	10-24[0_83]
10-21	1644-1655	pulsatility	abstract|abstract[83]|abstract[86]	giv|new[83]|new[86]	coref	11-15[94_0]
10-22	1656-1661	index	abstract[83]|abstract[86]	new[83]|new[86]	_	_
10-23	1662-1663	(	abstract[86]	new[86]	_	_
10-24	1664-1666	PI	abstract|abstract[86]	giv|new[86]	coref	10-31
10-25	1667-1668	)	abstract[86]	new[86]	_	_
10-26	1669-1676	control	event|abstract[86]	giv|new[86]	coref	13-15[113_0]
10-27	1677-1685	strategy	abstract[86]	new[86]	_	_
10-28	1686-1687	,	abstract[86]	new[86]	_	_
10-29	1688-1693	which	abstract[86]	new[86]	_	_
10-30	1694-1703	regulates	abstract[86]	new[86]	_	_
10-31	1704-1706	PI	abstract[86]|abstract	new[86]|giv	coref	11-38
10-32	1707-1715	directly	abstract[86]	new[86]	_	_
10-33	1716-1718	at	abstract[86]	new[86]	_	_
10-34	1719-1720	a	abstract[86]|abstract[88]	new[86]|new[88]	_	_
10-35	1721-1729	specific	abstract[86]|abstract[88]	new[86]|new[88]	_	_
10-36	1730-1735	stage	abstract[86]|abstract[88]	new[86]|new[88]	_	_
10-37	1736-1737	.	_	_	_	_

#Text=This allows the left ventricle to automatically adjust the RV output ( represented by the increased or decreased pump pulsatility ) , thereby decreasing the danger of suction or an inefficient pumping aid connected to improperly defined PI target values .
11-1	1738-1742	This	place	giv	_	_
11-2	1743-1749	allows	_	_	_	_
11-3	1750-1753	the	object[90]	new[90]	_	_
11-4	1754-1758	left	object[90]	new[90]	_	_
11-5	1759-1768	ventricle	object[90]	new[90]	_	_
11-6	1769-1771	to	_	_	_	_
11-7	1772-1785	automatically	_	_	_	_
11-8	1786-1792	adjust	_	_	_	_
11-9	1793-1796	the	abstract[92]	new[92]	_	_
11-10	1797-1799	RV	abstract|abstract[92]	new|new[92]	_	_
11-11	1800-1806	output	abstract[92]	new[92]	_	_
11-12	1807-1808	(	abstract[92]	new[92]	_	_
11-13	1809-1820	represented	abstract[92]	new[92]	_	_
11-14	1821-1823	by	abstract[92]	new[92]	_	_
11-15	1824-1827	the	abstract[92]|abstract[94]	new[92]|giv[94]	_	_
11-16	1828-1837	increased	abstract[92]|abstract[94]	new[92]|giv[94]	_	_
11-17	1838-1840	or	abstract[92]|abstract[94]	new[92]|giv[94]	_	_
11-18	1841-1850	decreased	abstract[92]|abstract[94]	new[92]|giv[94]	_	_
11-19	1851-1855	pump	abstract[92]|object|abstract[94]	new[92]|giv|giv[94]	_	_
11-20	1856-1867	pulsatility	abstract[92]|abstract[94]	new[92]|giv[94]	_	_
11-21	1868-1869	)	abstract[92]	new[92]	_	_
11-22	1870-1871	,	_	_	_	_
11-23	1872-1879	thereby	_	_	_	_
11-24	1880-1890	decreasing	_	_	_	_
11-25	1891-1894	the	abstract[95]	new[95]	_	_
11-26	1895-1901	danger	abstract[95]	new[95]	_	_
11-27	1902-1904	of	abstract[95]	new[95]	_	_
11-28	1905-1912	suction	abstract[95]|abstract	new[95]|new	_	_
11-29	1913-1915	or	abstract[95]	new[95]	_	_
11-30	1916-1918	an	abstract[95]|object[98]	new[95]|new[98]	_	_
11-31	1919-1930	inefficient	abstract[95]|object[98]	new[95]|new[98]	_	_
11-32	1931-1938	pumping	abstract[95]|abstract|object[98]	new[95]|new|new[98]	_	_
11-33	1939-1942	aid	abstract[95]|object[98]	new[95]|new[98]	_	_
11-34	1943-1952	connected	abstract[95]|object[98]	new[95]|new[98]	_	_
11-35	1953-1955	to	abstract[95]|object[98]	new[95]|new[98]	_	_
11-36	1956-1966	improperly	abstract[95]|object[98]|abstract[101]	new[95]|new[98]|new[101]	_	_
11-37	1967-1974	defined	abstract[95]|object[98]|abstract[101]	new[95]|new[98]|new[101]	_	_
11-38	1975-1977	PI	abstract[95]|object[98]|abstract|abstract[101]	new[95]|new[98]|giv|new[101]	coref	12-4
11-39	1978-1984	target	abstract[95]|object[98]|abstract|abstract[101]	new[95]|new[98]|new|new[101]	coref	12-3
11-40	1985-1991	values	abstract[95]|object[98]|abstract[101]	new[95]|new[98]|new[101]	_	_
11-41	1992-1993	.	_	_	_	_

#Text=The optimal target PI value depends on heart contractility , preload , and afterload .
12-1	1994-1997	The	abstract[104]	new[104]	_	_
12-2	1998-2005	optimal	abstract[104]	new[104]	_	_
12-3	2006-2012	target	abstract|abstract[104]	giv|new[104]	_	_
12-4	2013-2015	PI	abstract|abstract[104]	giv|new[104]	_	_
12-5	2016-2021	value	abstract[104]	new[104]	_	_
12-6	2022-2029	depends	_	_	_	_
12-7	2030-2032	on	_	_	_	_
12-8	2033-2038	heart	object|abstract[106]	new|new[106]	coref	31-15[141_106]
12-9	2039-2052	contractility	abstract[106]	new[106]	_	_
12-10	2053-2054	,	_	_	_	_
12-11	2055-2062	preload	abstract	giv	_	_
12-12	2063-2064	,	_	_	_	_
12-13	2065-2068	and	_	_	_	_
12-14	2069-2078	afterload	event	new	_	_
12-15	2079-2080	.	_	_	_	_

#Text=The methodology of this work is proposed to evaluate the merits of a full-state feedback control method involving sensorless and non-invasive approaches in a range of identical simulation scenarios .
13-1	2081-2084	The	abstract[109]	new[109]	_	_
13-2	2085-2096	methodology	abstract[109]	new[109]	_	_
13-3	2097-2099	of	abstract[109]	new[109]	_	_
13-4	2100-2104	this	abstract[109]|abstract[110]	new[109]|new[110]	_	_
13-5	2105-2109	work	abstract[109]|abstract[110]	new[109]|new[110]	_	_
13-6	2110-2112	is	_	_	_	_
13-7	2113-2121	proposed	_	_	_	_
13-8	2122-2124	to	_	_	_	_
13-9	2125-2133	evaluate	_	_	_	_
13-10	2134-2137	the	abstract[111]	new[111]	_	_
13-11	2138-2144	merits	abstract[111]	new[111]	_	_
13-12	2145-2147	of	abstract[111]	new[111]	_	_
13-13	2148-2149	a	abstract[111]|abstract[114]	new[111]|new[114]	coref	14-4[119_114]
13-14	2150-2160	full-state	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-15	2161-2169	feedback	abstract[111]|abstract|event[113]|abstract[114]	new[111]|new|giv[113]|new[114]	_	_
13-16	2170-2177	control	abstract[111]|event[113]|abstract[114]	new[111]|giv[113]|new[114]	_	_
13-17	2178-2184	method	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-18	2185-2194	involving	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-19	2195-2205	sensorless	abstract[111]|abstract[114]|abstract[115]	new[111]|new[114]|giv[115]	_	_
13-20	2206-2209	and	abstract[111]|abstract[114]|abstract[115]	new[111]|new[114]|giv[115]	_	_
13-21	2210-2222	non-invasive	abstract[111]|abstract[114]|abstract[115]	new[111]|new[114]|giv[115]	_	_
13-22	2223-2233	approaches	abstract[111]|abstract[114]|abstract[115]	new[111]|new[114]|giv[115]	_	_
13-23	2234-2236	in	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-24	2237-2238	a	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-25	2239-2244	range	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-26	2245-2247	of	abstract[111]|abstract[114]	new[111]|new[114]	_	_
13-27	2248-2257	identical	abstract[111]|abstract[114]|abstract[117]	new[111]|new[114]|new[117]	_	_
13-28	2258-2268	simulation	abstract[111]|abstract[114]|abstract|abstract[117]	new[111]|new[114]|new|new[117]	coref	31-3
13-29	2269-2278	scenarios	abstract[111]|abstract[114]|abstract[117]	new[111]|new[114]|new[117]	_	_
13-30	2279-2280	.	_	_	_	_

#Text=The results of this method show that the controller has advantages in regulating the reference signal generated with the safe mode at a variable speed , as illustrated in
14-1	2281-2284	The	abstract[118]	new[118]	_	_
14-2	2285-2292	results	abstract[118]	new[118]	_	_
14-3	2293-2295	of	abstract[118]	new[118]	_	_
14-4	2296-2300	this	abstract[118]|abstract[119]	new[118]|giv[119]	_	_
14-5	2301-2307	method	abstract[118]|abstract[119]	new[118]|giv[119]	_	_
14-6	2308-2312	show	_	_	_	_
14-7	2313-2317	that	_	_	_	_
14-8	2318-2321	the	person[120]	new[120]	_	_
14-9	2322-2332	controller	person[120]	new[120]	_	_
14-10	2333-2336	has	_	_	_	_
14-11	2337-2347	advantages	abstract[121]	new[121]	_	_
14-12	2348-2350	in	abstract[121]	new[121]	_	_
14-13	2351-2361	regulating	abstract[121]	new[121]	_	_
14-14	2362-2365	the	abstract[121]|abstract[123]	new[121]|new[123]	_	_
14-15	2366-2375	reference	abstract[121]|abstract|abstract[123]	new[121]|new|new[123]	_	_
14-16	2376-2382	signal	abstract[121]|abstract[123]	new[121]|new[123]	_	_
14-17	2383-2392	generated	abstract[121]|abstract[123]	new[121]|new[123]	_	_
14-18	2393-2397	with	abstract[121]|abstract[123]	new[121]|new[123]	_	_
14-19	2398-2401	the	abstract[121]|abstract[123]|abstract[124]	new[121]|new[123]|new[124]	_	_
14-20	2402-2406	safe	abstract[121]|abstract[123]|abstract[124]	new[121]|new[123]|new[124]	_	_
14-21	2407-2411	mode	abstract[121]|abstract[123]|abstract[124]	new[121]|new[123]|new[124]	_	_
14-22	2412-2414	at	abstract[121]	new[121]	_	_
14-23	2415-2416	a	abstract[121]|abstract[125]	new[121]|giv[125]	_	_
14-24	2417-2425	variable	abstract[121]|abstract[125]	new[121]|giv[125]	_	_
14-25	2426-2431	speed	abstract[121]|abstract[125]	new[121]|giv[125]	_	_
14-26	2432-2433	,	_	_	_	_
14-27	2434-2436	as	_	_	_	_
14-28	2437-2448	illustrated	_	_	_	_
14-29	2449-2451	in	_	_	_	_

#Text=Figure 4
15-1	2452-2458	Figure	abstract[126]	new[126]	_	_
15-2	2459-2460	4	abstract[126]	new[126]	_	_

#Text=,
16-1	2461-2462	,	_	_	_	_

#Text=Figure 5
17-1	2463-2469	Figure	abstract[127]	new[127]	_	_
17-2	2470-2471	5	abstract[127]	new[127]	_	_

#Text=,
18-1	2472-2473	,	_	_	_	_

#Text=Figure 6
19-1	2474-2480	Figure	abstract[128]	new[128]	_	_
19-2	2481-2482	6	abstract[128]	new[128]	_	_

#Text=,
20-1	2483-2484	,	_	_	_	_

#Text=Figure 7
21-1	2485-2491	Figure	abstract[129]	new[129]	_	_
21-2	2492-2493	7	abstract[129]	new[129]	_	_

#Text=,
22-1	2494-2495	,	_	_	_	_

#Text=Figure 8
23-1	2496-2502	Figure	abstract[130]	new[130]	_	_
23-2	2503-2504	8	abstract[130]	new[130]	_	_

#Text=,
24-1	2505-2506	,	_	_	_	_

#Text=Figure 9
25-1	2507-2513	Figure	abstract[131]	new[131]	_	_
25-2	2514-2515	9	abstract[131]	new[131]	_	_

#Text=,
26-1	2516-2517	,	_	_	_	_

#Text=Figure 10
27-1	2518-2524	Figure	abstract[132]	new[132]	_	_
27-2	2525-2527	10	abstract[132]	new[132]	_	_

#Text=and
28-1	2528-2531	and	_	_	_	_

#Text=Figure 11
29-1	2532-2538	Figure	abstract[133]	new[133]	_	_
29-2	2539-2541	11	abstract[133]	new[133]	_	_

#Text=.
30-1	2542-2543	.	_	_	_	_

#Text=The software simulation model currently simulates rest and exercise with changes in HR , cardiac contractility , and systemic vascular resistance .
31-1	2544-2547	The	abstract[136]	new[136]	coref	33-10[154_136]
31-2	2548-2556	software	abstract|abstract[136]	new|new[136]	coref	33-11
31-3	2557-2567	simulation	abstract|abstract[136]	giv|new[136]	coref	41-17
31-4	2568-2573	model	abstract[136]	new[136]	_	_
31-5	2574-2583	currently	_	_	_	_
31-6	2584-2593	simulates	_	_	_	_
31-7	2594-2598	rest	event	new	_	_
31-8	2599-2602	and	_	_	_	_
31-9	2603-2611	exercise	event	new	ana	32-3
31-10	2612-2616	with	_	_	_	_
31-11	2617-2624	changes	abstract[139]	new[139]	coref	32-7[144_139]
31-12	2625-2627	in	abstract[139]	new[139]	_	_
31-13	2628-2630	HR	abstract[139]|abstract	new[139]|new	_	_
31-14	2631-2632	,	abstract[139]	new[139]	_	_
31-15	2633-2640	cardiac	abstract[139]|abstract[141]	new[139]|giv[141]	_	_
31-16	2641-2654	contractility	abstract[139]|abstract[141]	new[139]|giv[141]	_	_
31-17	2655-2656	,	abstract[139]	new[139]	_	_
31-18	2657-2660	and	abstract[139]	new[139]	_	_
31-19	2661-2669	systemic	abstract[139]|abstract[142]	new[139]|new[142]	coref	36-10[166_142]
31-20	2670-2678	vascular	abstract[139]|abstract[142]	new[139]|new[142]	_	_
31-21	2679-2689	resistance	abstract[139]|abstract[142]	new[139]|new[142]	_	_
31-22	2690-2691	.	_	_	_	_

#Text=Clinically , it is observed that large changes in pump pulsatility during postural changes cause patients to sometimes feel weak during Valsalva maneuvers ( e.g. , when coughing or straining ) .
32-1	2692-2702	Clinically	_	_	_	_
32-2	2703-2704	,	_	_	_	_
32-3	2705-2707	it	event	giv	ana	33-5
32-4	2708-2710	is	_	_	_	_
32-5	2711-2719	observed	_	_	_	_
32-6	2720-2724	that	_	_	_	_
32-7	2725-2730	large	abstract[144]	giv[144]	coref	32-13[147_144]
32-8	2731-2738	changes	abstract[144]	giv[144]	_	_
32-9	2739-2741	in	abstract[144]	giv[144]	_	_
32-10	2742-2746	pump	abstract[144]|object|event[146]	giv[144]|new|new[146]	coref	38-17[0_146]
32-11	2747-2758	pulsatility	abstract[144]|event[146]	giv[144]|new[146]	_	_
32-12	2759-2765	during	abstract[144]	giv[144]	_	_
32-13	2766-2774	postural	abstract[144]|abstract[147]	giv[144]|giv[147]	_	_
32-14	2775-2782	changes	abstract[144]|abstract[147]	giv[144]|giv[147]	_	_
32-15	2783-2788	cause	_	_	_	_
32-16	2789-2797	patients	person	new	coref	34-13[158_0]
32-17	2798-2800	to	_	_	_	_
32-18	2801-2810	sometimes	_	_	_	_
32-19	2811-2815	feel	_	_	_	_
32-20	2816-2820	weak	_	_	_	_
32-21	2821-2827	during	_	_	_	_
32-22	2828-2836	Valsalva	person|event[150]	new|new[150]	coref	33-15[155_150]
32-23	2837-2846	maneuvers	event[150]	new[150]	_	_
32-24	2847-2848	(	_	_	_	_
32-25	2849-2853	e.g.	_	_	_	_
32-26	2854-2855	,	_	_	_	_
32-27	2856-2860	when	_	_	_	_
32-28	2861-2869	coughing	_	_	_	_
32-29	2870-2872	or	_	_	_	_
32-30	2873-2882	straining	_	_	_	_
32-31	2883-2884	)	_	_	_	_
32-32	2885-2886	.	_	_	_	_

#Text=Therefore , we believe it is important to improve the software model to represent these events .
33-1	2887-2896	Therefore	_	_	_	_
33-2	2897-2898	,	_	_	_	_
33-3	2899-2901	we	person	acc	ana	36-1
33-4	2902-2909	believe	_	_	_	_
33-5	2910-2912	it	event	giv	coref	35-14
33-6	2913-2915	is	_	_	_	_
33-7	2916-2925	important	_	_	_	_
33-8	2926-2928	to	_	_	_	_
33-9	2929-2936	improve	_	_	_	_
33-10	2937-2940	the	abstract[154]	giv[154]	_	_
33-11	2941-2949	software	abstract|abstract[154]	giv|giv[154]	_	_
33-12	2950-2955	model	abstract[154]	giv[154]	_	_
33-13	2956-2958	to	abstract[154]	giv[154]	_	_
33-14	2959-2968	represent	abstract[154]	giv[154]	_	_
33-15	2969-2974	these	abstract[154]|event[155]	giv[154]|giv[155]	_	_
33-16	2975-2981	events	abstract[154]|event[155]	giv[154]|giv[155]	_	_
33-17	2982-2983	.	_	_	_	_

#Text=In addition , the aortic valve is observed to be closed in most LVAD patients .
34-1	2984-2986	In	_	_	_	_
34-2	2987-2995	addition	_	_	_	_
34-3	2996-2997	,	_	_	_	_
34-4	2998-3001	the	object[156]	new[156]	coref	36-5[165_156]
34-5	3002-3008	aortic	object[156]	new[156]	_	_
34-6	3009-3014	valve	object[156]	new[156]	_	_
34-7	3015-3017	is	_	_	_	_
34-8	3018-3026	observed	_	_	_	_
34-9	3027-3029	to	_	_	_	_
34-10	3030-3032	be	_	_	_	_
34-11	3033-3039	closed	_	_	_	_
34-12	3040-3042	in	_	_	_	_
34-13	3043-3047	most	person[158]	giv[158]	_	_
34-14	3048-3052	LVAD	abstract|person[158]	new|giv[158]	coref	36-15
34-15	3053-3061	patients	person[158]	giv[158]	_	_
34-16	3062-3063	.	_	_	_	_

#Text=However , with a change in posture , cardiac recovery , and during exercise , it may open .
35-1	3064-3071	However	_	_	_	_
35-2	3072-3073	,	_	_	_	_
35-3	3074-3078	with	_	_	_	_
35-4	3079-3080	a	event[159]	new[159]	_	_
35-5	3081-3087	change	event[159]	new[159]	_	_
35-6	3088-3090	in	event[159]	new[159]	_	_
35-7	3091-3098	posture	event[159]|abstract	new[159]|new	_	_
35-8	3099-3100	,	event[159]	new[159]	_	_
35-9	3101-3108	cardiac	event[159]|event[161]	new[159]|new[161]	_	_
35-10	3109-3117	recovery	event[159]|event[161]	new[159]|new[161]	_	_
35-11	3118-3119	,	_	_	_	_
35-12	3120-3123	and	_	_	_	_
35-13	3124-3130	during	_	_	_	_
35-14	3131-3139	exercise	event	giv	ana	35-16
35-15	3140-3141	,	_	_	_	_
35-16	3142-3144	it	event	giv	_	_
35-17	3145-3148	may	_	_	_	_
35-18	3149-3153	open	_	_	_	_
35-19	3154-3155	.	_	_	_	_

#Text=We have found that the aortic valve offers a lower resistance pathway than the LVAD bypass route , as the native heart sometimes pumps a significant flow relative to that of the LVAD .
36-1	3156-3158	We	person	giv	ana	37-3
36-2	3159-3163	have	_	_	_	_
36-3	3164-3169	found	_	_	_	_
36-4	3170-3174	that	_	_	_	_
36-5	3175-3178	the	object[165]	giv[165]	_	_
36-6	3179-3185	aortic	object[165]	giv[165]	_	_
36-7	3186-3191	valve	object[165]	giv[165]	_	_
36-8	3192-3198	offers	_	_	_	_
36-9	3199-3200	a	abstract[167]	new[167]	_	_
36-10	3201-3206	lower	abstract[166]|abstract[167]	giv[166]|new[167]	_	_
36-11	3207-3217	resistance	abstract[166]|abstract[167]	giv[166]|new[167]	_	_
36-12	3218-3225	pathway	abstract[167]	new[167]	_	_
36-13	3226-3230	than	_	_	_	_
36-14	3231-3234	the	abstract[170]	new[170]	_	_
36-15	3235-3239	LVAD	abstract|abstract[170]	giv|new[170]	coref	36-32[173_0]
36-16	3240-3246	bypass	object|abstract[170]	new|new[170]	_	_
36-17	3247-3252	route	abstract[170]	new[170]	_	_
36-18	3253-3254	,	_	_	_	_
36-19	3255-3257	as	_	_	_	_
36-20	3258-3261	the	object[171]	new[171]	coref	40-15[0_171]
36-21	3262-3268	native	object[171]	new[171]	_	_
36-22	3269-3274	heart	object[171]	new[171]	_	_
36-23	3275-3284	sometimes	_	_	_	_
36-24	3285-3290	pumps	_	_	_	_
36-25	3291-3292	a	abstract[172]	new[172]	_	_
36-26	3293-3304	significant	abstract[172]	new[172]	_	_
36-27	3305-3309	flow	abstract[172]	new[172]	_	_
36-28	3310-3318	relative	abstract[172]	new[172]	_	_
36-29	3319-3321	to	abstract[172]	new[172]	_	_
36-30	3322-3326	that	abstract[172]	new[172]	_	_
36-31	3327-3329	of	abstract[172]	new[172]	_	_
36-32	3330-3333	the	abstract[172]|abstract[173]	new[172]|giv[173]	coref	42-18[0_173]
36-33	3334-3338	LVAD	abstract[172]|abstract[173]	new[172]|giv[173]	_	_
36-34	3339-3340	.	_	_	_	_

#Text=Therefore , we believe that this different pumping state could greatly impact our overall control strategy , and therefore requires online detection .
37-1	3341-3350	Therefore	_	_	_	_
37-2	3351-3352	,	_	_	_	_
37-3	3353-3355	we	person	giv	ana	37-13
37-4	3356-3363	believe	_	_	_	_
37-5	3364-3368	that	_	_	_	_
37-6	3369-3373	this	abstract[176]	new[176]	_	_
37-7	3374-3383	different	abstract[176]	new[176]	_	_
37-8	3384-3391	pumping	abstract|abstract[176]	new|new[176]	coref	38-27
37-9	3392-3397	state	abstract[176]	new[176]	_	_
37-10	3398-3403	could	_	_	_	_
37-11	3404-3411	greatly	_	_	_	_
37-12	3412-3418	impact	_	_	_	_
37-13	3419-3422	our	person|abstract[179]	giv|new[179]	ana	41-6
37-14	3423-3430	overall	abstract[179]	new[179]	_	_
37-15	3431-3438	control	event|abstract[179]	new|new[179]	_	_
37-16	3439-3447	strategy	abstract[179]	new[179]	_	_
37-17	3448-3449	,	_	_	_	_
37-18	3450-3453	and	_	_	_	_
37-19	3454-3463	therefore	_	_	_	_
37-20	3464-3472	requires	_	_	_	_
37-21	3473-3479	online	event[180]	new[180]	_	_
37-22	3480-3489	detection	event[180]	new[180]	_	_
37-23	3490-3491	.	_	_	_	_

#Text=In addition , during use in a clinical setting , it was found that controlling the pulsatility index to a pre-set point did not prevent antagonistic pumping states .
38-1	3492-3494	In	_	_	_	_
38-2	3495-3503	addition	_	_	_	_
38-3	3504-3505	,	_	_	_	_
38-4	3506-3512	during	_	_	_	_
38-5	3513-3516	use	event[181]	new[181]	_	_
38-6	3517-3519	in	event[181]	new[181]	_	_
38-7	3520-3521	a	event[181]|abstract[182]	new[181]|new[182]	ana	38-11[0_182]
38-8	3522-3530	clinical	event[181]|abstract[182]	new[181]|new[182]	_	_
38-9	3531-3538	setting	event[181]|abstract[182]	new[181]|new[182]	_	_
38-10	3539-3540	,	_	_	_	_
38-11	3541-3543	it	abstract	giv	_	_
38-12	3544-3547	was	_	_	_	_
38-13	3548-3553	found	_	_	_	_
38-14	3554-3558	that	_	_	_	_
38-15	3559-3570	controlling	_	_	_	_
38-16	3571-3574	the	abstract[185]	new[185]	coref	40-5[195_185]
38-17	3575-3586	pulsatility	event|abstract[185]	giv|new[185]	coref	40-6
38-18	3587-3592	index	abstract[185]	new[185]	_	_
38-19	3593-3595	to	_	_	_	_
38-20	3596-3597	a	abstract[186]	new[186]	_	_
38-21	3598-3605	pre-set	abstract[186]	new[186]	_	_
38-22	3606-3611	point	abstract[186]	new[186]	_	_
38-23	3612-3615	did	_	_	_	_
38-24	3616-3619	not	_	_	_	_
38-25	3620-3627	prevent	_	_	_	_
38-26	3628-3640	antagonistic	abstract[188]	new[188]	_	_
38-27	3641-3648	pumping	abstract|abstract[188]	giv|new[188]	_	_
38-28	3649-3655	states	abstract[188]	new[188]	_	_
38-29	3656-3657	.	_	_	_	_

#Text=On the contrary , occasional suction occurred , which led to the development of algorithms for anti-suction .
39-1	3658-3660	On	_	_	_	_
39-2	3661-3664	the	_	_	_	_
39-3	3665-3673	contrary	_	_	_	_
39-4	3674-3675	,	_	_	_	_
39-5	3676-3686	occasional	abstract[189]	new[189]	_	_
39-6	3687-3694	suction	abstract[189]	new[189]	_	_
39-7	3695-3703	occurred	_	_	_	_
39-8	3704-3705	,	_	_	_	_
39-9	3706-3711	which	_	_	_	_
39-10	3712-3715	led	_	_	_	_
39-11	3716-3718	to	_	_	_	_
39-12	3719-3722	the	event[190]	new[190]	_	_
39-13	3723-3734	development	event[190]	new[190]	_	_
39-14	3735-3737	of	event[190]	new[190]	_	_
39-15	3738-3748	algorithms	event[190]|abstract[191]	new[190]|new[191]	_	_
39-16	3749-3752	for	event[190]|abstract[191]	new[190]|new[191]	_	_
39-17	3753-3765	anti-suction	event[190]|abstract[191]|abstract	new[190]|new[191]|new	_	_
39-18	3766-3767	.	_	_	_	_

#Text=Another drawback is that the pulsatility index ( PI ) is increasingly dependent on heart rate .
40-1	3768-3775	Another	abstract[193]	new[193]	_	_
40-2	3776-3784	drawback	abstract[193]	new[193]	_	_
40-3	3785-3787	is	_	_	_	_
40-4	3788-3792	that	_	_	_	_
40-5	3793-3796	the	abstract[195]	giv[195]	appos	40-9[0_195]
40-6	3797-3808	pulsatility	event|abstract[195]	giv|giv[195]	_	_
40-7	3809-3814	index	abstract[195]	giv[195]	_	_
40-8	3815-3816	(	_	_	_	_
40-9	3817-3819	PI	abstract	giv	_	_
40-10	3820-3821	)	_	_	_	_
40-11	3822-3824	is	_	_	_	_
40-12	3825-3837	increasingly	_	_	_	_
40-13	3838-3847	dependent	_	_	_	_
40-14	3848-3850	on	_	_	_	_
40-15	3851-3856	heart	object|abstract[198]	giv|new[198]	_	_
40-16	3857-3861	rate	abstract[198]	new[198]	_	_
40-17	3862-3863	.	_	_	_	_

#Text=For real-time clinical studies , we plan to validate the controller built in the above-mentioned computer simulation studies in a pulsatile mock circulation loop .
41-1	3864-3867	For	_	_	_	_
41-2	3868-3877	real-time	abstract[199]	new[199]	coref	41-14[203_199]
41-3	3878-3886	clinical	abstract[199]	new[199]	_	_
41-4	3887-3894	studies	abstract[199]	new[199]	_	_
41-5	3895-3896	,	_	_	_	_
41-6	3897-3899	we	person	giv	_	_
41-7	3900-3904	plan	_	_	_	_
41-8	3905-3907	to	_	_	_	_
41-9	3908-3916	validate	_	_	_	_
41-10	3917-3920	the	object[201]	new[201]	coref	42-17[214_201]
41-11	3921-3931	controller	object[201]	new[201]	_	_
41-12	3932-3937	built	object[201]	new[201]	_	_
41-13	3938-3940	in	object[201]	new[201]	_	_
41-14	3941-3944	the	object[201]|abstract[203]	new[201]|giv[203]	coref	43-9[218_203]
41-15	3945-3960	above-mentioned	object[201]|abstract[203]	new[201]|giv[203]	_	_
41-16	3961-3969	computer	object[201]|abstract[203]	new[201]|giv[203]	_	_
41-17	3970-3980	simulation	object[201]|abstract|abstract[203]	new[201]|giv|giv[203]	_	_
41-18	3981-3988	studies	object[201]|abstract[203]	new[201]|giv[203]	_	_
41-19	3989-3991	in	_	_	_	_
41-20	3992-3993	a	abstract[205]	new[205]	ana	42-1[0_205]
41-21	3994-4003	pulsatile	abstract[205]	new[205]	_	_
41-22	4004-4008	mock	abstract[205]	new[205]	_	_
41-23	4009-4020	circulation	abstract|abstract[205]	new|new[205]	_	_
41-24	4021-4025	loop	abstract[205]	new[205]	_	_
41-25	4026-4027	.	_	_	_	_

#Text=This will include the design of a LabView/MATLAB system for the implementation of control strategies in the LVAD physical controller .
42-1	4028-4032	This	abstract	giv	_	_
42-2	4033-4037	will	_	_	_	_
42-3	4038-4045	include	_	_	_	_
42-4	4046-4049	the	abstract[207]	new[207]	_	_
42-5	4050-4056	design	abstract[207]	new[207]	_	_
42-6	4057-4059	of	abstract[207]	new[207]	_	_
42-7	4060-4061	a	abstract[207]|abstract[209]	new[207]|new[209]	coref	43-1[216_209]
42-8	4062-4076	LabView/MATLAB	abstract[207]|organization|abstract[209]	new[207]|new|new[209]	_	_
42-9	4077-4083	system	abstract[207]|abstract[209]	new[207]|new[209]	_	_
42-10	4084-4087	for	abstract[207]|abstract[209]	new[207]|new[209]	_	_
42-11	4088-4091	the	abstract[207]|abstract[209]|event[210]	new[207]|new[209]|new[210]	_	_
42-12	4092-4106	implementation	abstract[207]|abstract[209]|event[210]	new[207]|new[209]|new[210]	_	_
42-13	4107-4109	of	abstract[207]|abstract[209]|event[210]	new[207]|new[209]|new[210]	_	_
42-14	4110-4117	control	abstract[207]|abstract[209]|event[210]|person|abstract[212]	new[207]|new[209]|new[210]|new|new[212]	_	_
42-15	4118-4128	strategies	abstract[207]|abstract[209]|event[210]|abstract[212]	new[207]|new[209]|new[210]|new[212]	_	_
42-16	4129-4131	in	abstract[207]|abstract[209]|event[210]|abstract[212]	new[207]|new[209]|new[210]|new[212]	_	_
42-17	4132-4135	the	abstract[207]|abstract[209]|event[210]|abstract[212]|object[214]	new[207]|new[209]|new[210]|new[212]|giv[214]	_	_
42-18	4136-4140	LVAD	abstract[207]|abstract[209]|event[210]|abstract[212]|abstract|object[214]	new[207]|new[209]|new[210]|new[212]|giv|giv[214]	_	_
42-19	4141-4149	physical	abstract[207]|abstract[209]|event[210]|abstract[212]|object[214]	new[207]|new[209]|new[210]|new[212]|giv[214]	_	_
42-20	4150-4160	controller	abstract[207]|abstract[209]|event[210]|abstract[212]|object[214]	new[207]|new[209]|new[210]|new[212]|giv[214]	_	_
42-21	4161-4162	.	_	_	_	_

#Text=This computer system will then be used in acute animal studies .
43-1	4163-4167	This	abstract[216]	giv[216]	_	_
43-2	4168-4176	computer	object|abstract[216]	new|giv[216]	_	_
43-3	4177-4183	system	abstract[216]	giv[216]	_	_
43-4	4184-4188	will	_	_	_	_
43-5	4189-4193	then	_	_	_	_
43-6	4194-4196	be	_	_	_	_
43-7	4197-4201	used	_	_	_	_
43-8	4202-4204	in	_	_	_	_
43-9	4205-4210	acute	abstract[218]	giv[218]	_	_
43-10	4211-4217	animal	animal|abstract[218]	new|giv[218]	_	_
43-11	4218-4225	studies	abstract[218]	giv[218]	_	_
43-12	4226-4227	.	_	_	_	_
